21810 Federal Register / Vol. 74, No. 89 / Monday, May 11, 2009 / Notices 

Revision—National Center on Birth 

Defects and Developmental Disabilities 

(NCBDDD), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The National Center on Birth Defects 

and Developmental Disabilities at CDC 

promotes the health of babies, children, 

and adults with disabilities. As part of 

these efforts the Center is actively 

involved in addressing hearing loss (HL) 

among newborns and infants. HL is a 

common birth defect that affects 

approximately 12,000 infants each year 

and, when left undetected, can result in 

developmental delays. As awareness 

about infant HL increases, so does the 

demand for accurate information about 

rates of screening, referral, loss to 

follow-up, and incidence. This 

information is important for helping to 

ensure infants and children are 

receiving recommended screening and 

follow-up services, documenting the 

occurrence and etiology of differing 

degrees of HL among infants, and 

determining the overall impact of infant 

HL on future outcomes, such as 

cognitive development, and family 

dynamics. These data will also assist 

state Early Hearing Detection and 

Intervention (EHDI) programs with 

quality improvement activities and 

provide information that will be helpful 

in assessing the impact of federal 

initiatives. The public will be able to 

access this information via the CDC 

EHDI Web site (http://www.cdc.gov/ 

ncbddd/ehdi/data.htm). 

Given the lack of a standardized and 

readily accessible source of data, the 

CDC EHDI program developed a survey 

to be used annually that utilizes 

uniform definitions to collect aggregate, 

standardized EHDI data from states and 

territories. The request to complete this 

survey is planned to be disseminated to 

respondents via an e-mail, which will 

include a summary of the request and 

other relevant information. Minor 

changes to this survey, based on 

respondent feedback, are planned in 

order to make the survey easier to 

complete and further improve data 

quality. These changes include splitting 

the previously combined questions 

about the number of infants that died 

and parents refused into two separate 

questions, adding a question about how 

many infants with hearing loss are 

receiving only monitoring services, 

simplifying the table for reporting type 

and severity of hearing loss data, and 

expanding the maternal race categories 

in the demographic section. 

There are no costs to the respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

State and territory EHDI Program Coordinators .............................................. 53 1 4 212 

Dated: May 5, 2009. 

Marilyn S. Radke, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–10937 Filed 5–8–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–09–08BL] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–6974. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Multi-site HIV Testing in Community 

Mental Health Settings Serving African 

Americans—New—National Center for 

HIV, Viral Hepatitis, STD and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

People with severe mental illness, 

including those with substance use 

disorders, are at increased risk of 

infection with human 

immunodeficiency virus (HIV) when 

compared with the general population. 

However, not enough is known about 

the risk behaviors, willingness to be 

tested for HIV, and prevalence of HIV 

among persons with severe mental 

illness. In addition, the interrelations 

among diagnosis of HIV, compliance 

with medical care, subsequent risk 

behaviors, and the course of mental 

illness have not been well-described. 

Mental health clinics are an important 

setting for testing and promoting 

prevention efforts against the 

transmission of HIV. 

The objectives of this project are to (1) 

demonstrate improved access to HIV 

testing and linkage to care in 

participating mental health care settings 

and (2) describe the relationship 

between mental illness, HIV risk 

behaviors, and access to testing and 

services, in order to inform the 

development of optimal prevention 

interventions for persons with severe 

mental illness. Staff at selected 

implementation sites will offer testing 

for HIV to clients and administer a brief 

survey to assess risk behaviors, previous 

access to similar testing services, and 

mental health symptoms. This project 

will collect data from clients using brief 

surveys administered on a voluntary 

basis. Collection of data will provide 

information on client demographics; 

current behaviors that may facilitate 

HIV transmission, including sexual and 

drug-use behaviors; current psychiatric 

symptoms, determined using brief rating 

scales; access and barriers to HIV 

testing, prevention, and treatment 

services; and adherence to psychiatric 

and medical treatment regimens. CDC is 

requesting approval for a 2-year 

clearance for data collection. Data will 

be collected in 6 sites which provide 

mental health services. 

The goal will be to approach 716 

persons annually for participation in the 

study and interview a total of 600 

persons. Based on the University of 

Pennsylvania’s prior experience 

working in mental health settings, it is 

estimated that of the 716 approached for 

participation in the study, the response 

rate will be approximately 90%. Of the 

644 persons approached who agree to be 

Federal Register / Vol. 74, No. 89 / Monday, May 11, 2009 / Notices 21811 

surveyed, it is estimated that 95% of 

persons will meet the eligibility criteria 

and 98% will be able to provide 

informed consent, as determined by the 

consent comprehension test. Therefore, 

the goal will be to interview a sample 

of 600 persons annually for two years; 

300 in each of the two project areas of 

Baltimore and Philadelphia. The 

structured interview will take 

approximately 20 minutes to complete. 

Participation is voluntary. Data 

collection will provide important 

insights into the relationship between 

psychiatric illness and risk behaviors for 

HIV. 

There is no cost to the respondents 

other than their time. The total 

annualized burden hours are 313. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Approached individual ..................................... Eligibility Screener .......................................... 644 1 1/60 

Eligible participant ........................................... Consent Questionnaire .................................. 612 1 10/60 

Consented participant ..................................... Core Questionnaire ........................................ 600 1 20/60

Dated: May 5, 2009. 

Marilyn S. Radke, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–10938 Filed 5–8–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Institutes of Health Peer 

Review Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Institutes of 

Health Peer Review Advisory Committee. 

Date: June 8, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: Provide technical and scientific 

advice and recommendations to the NIH 

Director, the Deputy Director for Extramural 

Research, and the Director of the Center for 

Scientific Review (CSR) on all procedures 

and policies related to the process of peer 

review by which the scientific and technical 

merit of NIH grant applications is assessed. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Cheryl A. Kitt, PhD, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3030, 

MSC 7776, Bethesda, MD 20892, 301–435– 

1112, kittc@csr.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 04, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–10781 Filed 5–8–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; RFA–AA–09–006— 

Mechanism of Alcohol-Induced Organ 

Damage (R01). 

Date: July 13–14, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Philippe Marmillot, PhD, 

National Institutes of Health, National 

Institute on Alcohol Abuse and Alcoholism, 

5635 Fishers Lane, Rm 2017, Bethesda, MD 

20892, 301–443–2861, 

marmillotp@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.891, Alcohol Research Center 

Grants, National Institutes of Health, HHS) 

Dated: May 4, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–10786 Filed 5–8–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.